| Dr Laura Louise Shively, MD | |
|
4315 Diplomacy Dr, Anmc Otolaryngology Department, Anchorage, AK 99508-5926 | |
| (907) 729-1400 | |
| Not Available |
| Full Name | Dr Laura Louise Shively |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 11 Years |
| Location | 4315 Diplomacy Dr, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174797088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 7920 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
| Entity Name | Alaska Native Tribal Health Consortium |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
| Entity Name | Yukon-kuskokwim Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447477815 PECOS PAC ID: 5193718765 Enrollment ID: O20040407001515 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
| Entity Name | Kodiak Area Native Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679514236 PECOS PAC ID: 8426959297 Enrollment ID: O20041004000838 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
| Entity Name | Maniilaq Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861698805 PECOS PAC ID: 6103881792 Enrollment ID: O20041123000372 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
| Entity Name | Tanana Chiefs Conference |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821201278 PECOS PAC ID: 9537050109 Enrollment ID: O20050111000954 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Laura Louise Shively, MD 4315 Diplomacy Dr, Anmc Otolaryngology Department, Anchorage, AK 99508-5926 Ph: (907) 729-1400 | Dr Laura Louise Shively, MD 4315 Diplomacy Dr, Anmc Otolaryngology Department, Anchorage, AK 99508-5926 Ph: (907) 729-1400 |
News Archive
Cardiovascular disease will kill nearly 2.5 million people in the United States this year, according to the Centers for Disease Control. Over time, inflammation, collagen deposition and scar tissue formation can cause blood vessels to stiffen, a process called vascular fibrosis. Though researchers have known that the hormone aldosterone (Aldo) plays a role in this process, the precise mechanisms have been poorly understood.
A new vaccine designed at The Rockefeller University boosted a type of fast-responding immune system cell called the natural killer T (NKT) cell in patients with advanced cancer. The study surprised researchers by revealing the ability of these NKT cells to spur other, slower-responding immune cells to go to work.
Biomedical engineers have developed a way to deliver drugs to specific types of neurons in the brain, providing an unprecedented ability to study neurological diseases while also promising a more targeted way to treat them.
A state program that guarantees access to health coverage for all New Jersey residents regardless of their age or health status may be in jeopardy, according to a new study by The Center for State Health Policy (CSHP) at Rutgers, The State University of New Jersey.
› Verified 8 days ago
Dr. Jamie Swartz, DO Otolaryngology Medicare: Medicare Enrolled Practice Location: 673 Mdg/sghq, 5955 Zeamer Ave, Anchorage, AK 99506 Phone: 907-580-1035 | |
Christopher Edward Kowalski, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3841 Piper St., Suite T-230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Dr. Mark B. Lorenz, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3730 Rhone Cir Ste 203, Anchorage, AK 99508 Phone: 907-563-3515 Fax: 907-563-3541 | |
Jack Arlyn Smith, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4001 Dale St, #201, Anchorage, AK 99508 Phone: 907-561-1185 | |
Dr. James E Kallman, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3841 Piper St, Suite T230, Anchorage, AK 99508 Phone: 907-279-8800 Fax: 907-279-8810 | |
Randall Leslie Plant, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Attn: Sherry Reedy, Anchorage, AK 99508 Phone: 907-729-3971 Fax: 907-729-1542 |